The results showed that METTL3, β-catenin, c-Myc, SLC2A1, LDHA and HK2 expression were higher in HCC tumors with high expression of SLC2A1-DT than in HCC tumors with low expression of SLC2A1-DT (Fig. 8A-C, Fig. S8A). This evidence concerns the gene METTL3 and hepatocellular carcinoma.